Published in AJR Am J Roentgenol on August 01, 2009
Noninvasive cell-tracking methods. Nat Rev Clin Oncol (2011) 2.26
Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol (2013) 2.05
Magnetic particle imaging with tailored iron oxide nanoparticle tracers. IEEE Trans Med Imaging (2014) 1.91
Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.73
Iron administration before stem cell harvest enables MR imaging tracking after transplantation. Radiology (2013) 1.70
Assessing the efficacy of nano- and micro-sized magnetic particles as contrast agents for MRI cell tracking. PLoS One (2014) 1.54
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med (2012) 1.53
MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability. Nat Mater (2013) 1.53
Photoacoustic imaging of mesenchymal stem cells in living mice via silica-coated gold nanorods. ACS Nano (2012) 1.51
(19)F MRI for quantitative in vivo cell tracking. Trends Biotechnol (2010) 1.49
A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. Nat Nanotechnol (2011) 1.47
Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn Reson Med (2010) 1.46
Clinical imaging in regenerative medicine. Nat Biotechnol (2014) 1.43
Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J Am Chem Soc (2011) 1.41
Stem cell therapies for spinal cord injury. Nat Rev Neurol (2010) 1.35
Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking. Theranostics (2013) 1.33
Seeing stem cells at work in vivo. Stem Cell Rev (2014) 1.28
Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis. Magn Reson Med (2012) 1.16
Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. Magn Reson Med (2014) 1.15
Nanoparticle contrast agents for computed tomography: a focus on micelles. Contrast Media Mol Imaging (2014) 1.11
Labeling stem cells with ferumoxytol, an FDA-approved iron oxide nanoparticle. J Vis Exp (2011) 1.09
Mesenchymal stem cell labeling and in vitro MR characterization at 1.5 T of new SPIO contrast agent: Molday ION Rhodamine-B™. Contrast Media Mol Imaging (2010) 1.09
Clinically translatable cell tracking and quantification by MRI in cartilage repair using superparamagnetic iron oxides. PLoS One (2011) 1.07
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents. Int J Nanomedicine (2015) 1.02
Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles. Magn Reson Med (2010) 1.02
Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI. Nanomedicine (Lond) (2013) 1.01
Nanoparticle-based monitoring of cell therapy. Nanotechnology (2011) 1.01
Intracellular aggregation of multimodal silica nanoparticles for ultrasound-guided stem cell implantation. Sci Transl Med (2013) 1.00
MPI Cell Tracking: What Can We Learn from MRI? Proc SPIE Int Soc Opt Eng (2011) 0.99
Magnetic nanoparticles as intraocular drug delivery system to target retinal pigmented epithelium (RPE). Int J Mol Sci (2014) 0.98
Nanoparticles for imaging: top or flop? Radiology (2014) 0.97
Imaging approaches for the study of cell-based cardiac therapies. Nat Rev Cardiol (2009) 0.96
Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI. Contrast Media Mol Imaging (2012) 0.95
Magnetic Particle Imaging tracks the long-term fate of in vivo neural cell implants with high image contrast. Sci Rep (2015) 0.95
Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods. Int J Nanomedicine (2015) 0.93
Long-term MRI cell tracking after intraventricular delivery in a patient with global cerebral ischemia and prospects for magnetic navigation of stem cells within the CSF. PLoS One (2014) 0.91
Nanoparticles based stem cell tracking in regenerative medicine. Theranostics (2013) 0.91
Clinically viable magnetic poly(lactide-co-glycolide) particles for MRI-based cell tracking. Magn Reson Med (2014) 0.90
MRI/SPECT/Fluorescent Tri-Modal Probe for Evaluating the Homing and Therapeutic Efficacy of Transplanted Mesenchymal Stem Cells in a Rat Ischemic Stroke Model. Adv Funct Mater (2015) 0.90
Advances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicine. Dis Model Mech (2015) 0.89
Accelerated fluorine-19 MRI cell tracking using compressed sensing. Magn Reson Med (2012) 0.89
Radiolabeling and in vivo imaging of transplanted renal lineages differentiated from human embryonic stem cells in fetal rhesus monkeys. Mol Imaging Biol (2012) 0.88
Superparamagnetic iron oxide is suitable to label tendon stem cells and track them in vivo with MR imaging. Ann Biomed Eng (2013) 0.88
Magnetic resonance imaging of blood brain/nerve barrier dysfunction and leukocyte infiltration: closely related or discordant? Front Neurol (2012) 0.88
Imaging cardiac stem cell therapy: translations to human clinical studies. J Cardiovasc Transl Res (2011) 0.87
Microencapsulated cell tracking. NMR Biomed (2012) 0.86
Labeling and Imaging of Stem Cells - Promises and Concerns. Transfus Med Hemother (2010) 0.86
Is there a path beyond BOLD? Molecular imaging of brain function. Neuroimage (2012) 0.86
Dual-modality, dual-functional nanoprobes for cellular and molecular imaging. Theranostics (2012) 0.86
Overexpression of the MRI Reporter Genes Ferritin and Transferrin Receptor Affect Iron Homeostasis and Produce Limited Contrast in Mesenchymal Stem Cells. Int J Mol Sci (2015) 0.86
Neural precursors exhibit distinctly different patterns of cell migration upon transplantation during either the acute or chronic phase of EAE: a serial MR imaging study. Magn Reson Med (2011) 0.85
Orthopaedic applications of nanoparticle-based stem cell therapies. Stem Cell Res Ther (2012) 0.85
Tracking T-cells in vivo with a new nano-sized MRI contrast agent. Nanomedicine (2012) 0.85
Design of targeted cardiovascular molecular imaging probes. J Nucl Med (2010) 0.84
Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells. Stem Cells Int (2013) 0.84
Personalized nanomedicine advancements for stem cell tracking. Adv Drug Deliv Rev (2012) 0.84
Cell tracking in cardiac repair: what to image and how to image. Eur Radiol (2011) 0.84
Monitoring of Liver Cell Transplantation in a Preclinical Swine Model Using Magnetic Resonance Imaging. Cell Med (2010) 0.84
CARS microscopy for the visualization of micrometer-sized iron oxide MRI contrast agents in living cells. Biomed Opt Express (2011) 0.83
Functionalized nanostructures with application in regenerative medicine. Int J Mol Sci (2012) 0.83
Magnetically Targeted Stem Cell Delivery for Regenerative Medicine. J Funct Biomater (2015) 0.83
MR-guided portal vein delivery and monitoring of magnetocapsules: assessment of physiologic effects on the liver. J Vasc Interv Radiol (2011) 0.83
MR monitoring of minimally invasive delivery of mesenchymal stem cells into the porcine intervertebral disc. PLoS One (2013) 0.83
Nanoparticles and clinically applicable cell tracking. Br J Radiol (2015) 0.83
Essential Elements to Consider for MRI Cell Tracking Studies with Iron Oxide-based Labeling Agents. J Basic Clin Med (2012) 0.82
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases. Nanomedicine (2015) 0.82
Quantitative "Hot Spot" Imaging of Transplanted Stem Cells using Superparamagnetic Tracers and Magnetic Particle Imaging (MPI). Tomography (2015) 0.82
Controllable labelling of stem cells with a novel superparamagnetic iron oxide-loaded cationic nanovesicle for MR imaging. Eur Radiol (2012) 0.81
High-field small animal magnetic resonance oncology studies. Phys Med Biol (2013) 0.81
In vivo, multimodal imaging of B cell distribution and response to antibody immunotherapy in mice. PLoS One (2010) 0.81
Tracking stem cells for cardiovascular applications in vivo: focus on imaging techniques. Imaging Med (2011) 0.81
Theranostic Magnetic Nanostructures (MNS) for Cancer. Cancer Treat Res (2015) 0.81
Fluorine-19 Labeling of Stromal Vascular Fraction Cells for Clinical Imaging Applications. Stem Cells Transl Med (2015) 0.81
Could magnetic resonance provide in vivo histology? Front Genet (2014) 0.81
Automated detection and characterization of SPIO-labeled cells and capsules using magnetic field perturbations. Magn Reson Med (2011) 0.81
Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.81
Enabling non-invasive assessment of an engineered endothelium on ePTFE vascular grafts without increasing oxidative stress. Biomaterials (2015) 0.81
Use of Magnetocapsules for In Vivo Visualization and Enhanced Survival of Xenogeneic HepG2 Cell Transplants. Cell Med (2012) 0.80
FMN-coated fluorescent USPIO for cell labeling and non-invasive MR imaging in tissue engineering. Theranostics (2014) 0.79
Imaging transplanted stem cells in real time using an MRI dual-contrast method. Sci Rep (2015) 0.79
Label-free magnetic resonance imaging to locate live cells in three-dimensional porous scaffolds. J R Soc Interface (2012) 0.79
Longitudinal tracking of human dendritic cells in murine models using magnetic resonance imaging. Magn Reson Med (2010) 0.79
Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T₂ Contrast Agents for MRI. Int J Mol Sci (2016) 0.79
Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma. Sci Transl Med (2017) 0.78
Labeling of mesenchymal stem cells for MRI with single-cell sensitivity. Int J Nanomedicine (2016) 0.78
Magnetic resonance imaging of transplanted stem cell fate in stroke. J Res Med Sci (2014) 0.78
Non-Temperature Induced Effects of Magnetized Iron Oxide Nanoparticles in Alternating Magnetic Field in Cancer Cells. PLoS One (2016) 0.78
Advances in Molecular Imaging Strategies for In Vivo Tracking of Immune Cells. Biomed Res Int (2016) 0.77
In vivo tracking techniques for cellular regeneration, replacement, and redirection. J Nucl Med (2012) 0.77
Labeling human embryonic stem-cell-derived cardiomyocytes for tracking with MR imaging. Pediatr Radiol (2011) 0.77
MRI of magnetically labeled mesenchymal stem cells in hepatic failure model. World J Gastroenterol (2010) 0.77
Evaluating the effectiveness of transferrin receptor-1 (TfR1) as a magnetic resonance reporter gene. Contrast Media Mol Imaging (2016) 0.77
Science to Practice: Highly shifted proton MR imaging--a shift toward better cell tracking? Radiology (2014) 0.77
Imaging the paediatric lung: what does nanotechnology have to offer? Paediatr Respir Rev (2011) 0.77
Sensitivity of susceptibility-weighted imaging in detecting superparamagnetic iron oxide-labeled mesenchymal stem cells: a comparative study. Iran J Radiol (2015) 0.77
In Vivo Micro-CT Imaging of Human Mesenchymal Stem Cells Labeled with Gold-Poly-L-Lysine Nanocomplexes. Adv Funct Mater (2016) 0.76
Pre- and postmortem imaging of transplanted cells. Int J Nanomedicine (2015) 0.76
In vivo imaging of therapy-induced anti-cancer immune responses in humans. Cell Mol Life Sci (2012) 0.76
Bioengineering and regenerative medicine: keeping track. Nat Mater (2013) 0.76
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26
International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A (1993) 11.95
Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed (2004) 6.94
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol (2005) 5.80
Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood (2004) 4.66
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol (2001) 4.54
In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation (2003) 4.00
Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol (2007) 3.87
Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology (2003) 3.71
Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol (1989) 3.59
Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A (2002) 3.27
A new transgene reporter for in vivo magnetic resonance imaging. Nat Med (2005) 2.85
Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nat Clin Pract Oncol (2008) 2.61
Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med (2005) 2.55
Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed (2004) 2.54
Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med (2007) 2.49
Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia (2005) 2.41
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res (2003) 2.32
Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat Med (2007) 2.08
Catheter-based endomyocardial injection with real-time magnetic resonance imaging. Circulation (2002) 2.08
Imaging the expression of transfected genes in vivo. Cancer Res (1995) 2.05
Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant (2008) 2.03
Tracking neural stem cells in patients with brain trauma. N Engl J Med (2006) 1.95
Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med (2005) 1.88
Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn Reson Med (2007) 1.88
Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine. Circulation (2003) 1.78
Intracellular labeling of T-cells with superparamagnetic contrast agents. Magn Reson Med (1993) 1.76
Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide. Eur Radiol (2006) 1.75
Monitoring cell therapy using iron oxide MR contrast agents. Curr Pharm Biotechnol (2004) 1.71
Developing MR reporter genes: promises and pitfalls. NMR Biomed (2007) 1.70
Cellular MRI contrast via coexpression of transferrin receptor and ferritin. Magn Reson Med (2006) 1.64
Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol (2002) 1.53
Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Res (2009) 1.49
MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn Reson Med (2008) 1.46
Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int J Cancer (2007) 1.42
Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med (1992) 1.33
Magnetic resonance tracking of magnetically labeled autologous bone marrow CD34+ cells transplanted into the spinal cord via lumbar puncture technique in patients with chronic spinal cord injury: CD34+ cells' migration into the injured site. Stem Cells Dev (2007) 1.31
Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol (2008) 1.26
Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants. Exp Neurol (1993) 1.25
Effects of gadolinium-based magnetic resonance imaging contrast agents on human skin in organ culture and human skin fibroblasts. Invest Radiol (2009) 1.22
MR-trackable intramyocardial injection catheter. Magn Reson Med (2004) 1.19
Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn Reson Med (2003) 1.17
Stem cell therapy: MRI guidance and monitoring. J Magn Reson Imaging (2008) 1.17
Cytokine profile of iron-laden macrophages: implications for cellular magnetic resonance imaging. J Neuroimmunol (2005) 1.17
MR imaging of lineage-restricted neural precursors following transplantation into the adult spinal cord. Exp Neurol (2006) 1.15
Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis. Eur J Radiol (2008) 1.13
Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med (1993) 1.11
In vivo tracking of cellular therapeutics using magnetic resonance imaging. Expert Opin Biol Ther (2009) 1.06
Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium. Adv Dermatol (2007) 1.05
Frequency dependence of MR relaxation times. II. Iron oxides. J Magn Reson Imaging (1993) 1.03
Nephrogenic systemic fibrosis: more questions and some answers. Nephron Clin Pract (2008) 1.00
Magnetic resonance imaging of cells in experimental disease models. Prog Nucl Magn Reson Spectrosc (2009) 0.92
Technology Insight: vaccine therapy for prostate cancer. Nat Clin Pract Urol (2005) 0.87